Orthofix Medical Inc. (OFIX)

Market Cap	415.94M -11.5%
Revenue (ttm)	825.37M +2.6%
Net Income	-60.01M
EPS	-1.51
Shares Out	40.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	324,760
Open	10.33
Previous Close	10.34
Day's Range	10.20 - 10.58
52-Week Range	9.13 - 16.99
Beta	0.71
Analysts	Buy
Price Target	15.00 (+45.77%)
Earnings Date	May 5, 2026

About OFIX

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graf...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 1,605
• Stock Exchange: NASDAQ
• Ticker Symbol: OFIX
• Website: https://orthofix.com

Financial Performance

In 2025, Orthofix Medical's revenue was $822.31 million, an increase of 2.85% compared to the previous year's $799.49 million. Losses were -$92.19 million, -26.83% less than in 2024.

Analyst Summary

According to 5 analysts, the average rating for OFIX stock is "Buy." The 12-month stock price target is $15.0, which is an increase of 45.77% from the latest price.

Price Target

$15.0

(45.77% upside)

Analyst Consensus: Buy